Monday 18 April 2022

  INTIMATION FOR BODHIKA SEMINAR - 20/04/2022

DEPARTMENT  OF  AGADA TANTRA  AND VYAVAHAR  AYURVEDA

GOVT. AYURVEDA COLLEGE, THIRUVANANTHAPURAM

NAME  OF  FIRST PRESENTEE : Dr SHREEKALA MOHAN

THESIS TITLE: INVITRO ANTI INFLAMMATORY EFFECT OF BHOONIMBADI CHOORNAM  IN ULCERATIVE COLITIS- DLD1 COLORECTAL CELLS


NAME OF GUIDE: Dr  JAYSREE M N   

DATE: 20/04/2022

TIME: 2:00-4:00 PM

VENUE: HYBRID / MICROSOFT TEAMS 

ABSTRACT

Ulcerative colitis is a chronic inflammatory bowel disease of unknown aetiology that results in inflammation and ulcers of colon and rectum. The primary symptoms of active disease are abdominal pain, diarrhea mixed with blood and mucus, tenesmus etc. and marked by alternating periods of exacerbations and remission.  Ulcerative colitis has evolved into a global burden given its high incidence in developed countries and the substantial increase in incidence in developing countries. In conventional western medicine some drugs like sulfasalazine may give mild relief in symptoms and signs but after sometime patients need more doses of the same drug. Some patients get benefit with steroids such as prednisone which again are not suitable because of their side-effects. Even after taking steroids and sulfasalazine drugs patients suffer from the disease. So the patients are always seeking some alternative therapy promising more effective and safer outcomes.

       The present study focuses on invitro analysis of anti-inflammatory effect of Bhoonimbadi choornam in Ulcerative colitis DLD1 colorectal cells. Bhoonimbadi choornam mentioned in the context of visha atisara chikitsa (diarrhoea) under Vishopadrava pratisheda adyaya in Ashtanga Samgraha uthara sthana. Atisara has long been recognized as an important health problem in all age groups and is a major cause of morbidity and mortality.  The formulation contains 7 drugs such as Bhoonimba (Andrographis paniculata), Musta (Cyperus Rotundus), Katuka (Picrorrhiza kurroa), Trayanti (Bacopa monnieri), Indrayava (Holarrhena antidysenterica seed), Chitraka (Plumbago zeylanica) and Kutaja twak (Holarrhena antidysenterica). The study evaluates the anti-inflammatory effect of Bhoonimbadi choornam on Lipopolysaccharide activated DLD1 colorectal cells by using inflammatory assays such as Cyclo oxygenase, Lipoxygenase, Myelo peroxidase, Cellular nitrite and Inducible Nitric oxide synthase and results of sample drug is compared with a standard anti-inflammatory drug Sulfasalazine currently used in the treatment of Ulcerative colitis. 



NAME  OF  SECOND  PRESENTEE : Dr  SUPARYA G S

THESIS TITLE: EFFECT OF KARANJA TANKANA LEPA ALONG WITH PUNARNAVADI KASHAYA IN PALMOPLANTAR PSORIASIS

NAME OF GUIDE: Dr   JAYSREE M N 
 
DATE: 20/04/2022

TIME: 2:00-4:00 PM

VENUE: HYBRID / MICROSOFT TEAMS 

ABSTRACT

Psoriasis is recognized as the most prevalent immune-mediated inflammatory disease, involving skin and joints and associated with abnormalities of other systems.  Palmoplantar psoriasis is a variant of psoriasis in which there are erythematous, scaly, indurated at times fissured, plaques localized to palms and soles. Though only small body surface area is affected but because of the discomfort produced, this site of involvement carries a definite significance. Palmoplantar psoriasis is such a disease which can’t be correlated exactly with any disease mentioned in Ayurveda but to a certain extent based on its symptoms it can be correlated with Vipadika, which is one of the type of Kshudrakushtha. It involves predominantly Vata and Kapha dosha and characterized by Pani-pada Sphutana(Fissure in palm and soles) and Teevra vedana (with severe pain).

It was an interventional study with a sample size of 27 which was conducted in the OPD of Agadatantra department, Poojappura campus, Government Ayurveda college Thiruvananthapuram in the age group of 20-60 years of both sexes. Subjects satisfying inclusion criteria was selected and details were recorded as per the case proforma. The selected lepa which is prepared out of Karanja taila added with Tankana were given twice daily externally and punarnavadi kashaya 48 ml twice daily one hour before food internally for a period of 30 days. Follow up was done after 14 days. Assessment were done before treatment, after treatment and after follow up with the aid of ESFI score. Results were analysed statistically.



No comments: